Colorectal cancer statistics, 2017
- PMID: 28248415
- DOI: 10.3322/caac.21395
Colorectal cancer statistics, 2017
Abstract
Colorectal cancer (CRC) is one of the most common malignancies in the United States. Every 3 years, the American Cancer Society provides an update of CRC incidence, survival, and mortality rates and trends. Incidence data through 2013 were provided by the Surveillance, Epidemiology, and End Results program, the National Program of Cancer Registries, and the North American Association of Central Cancer Registries. Mortality data through 2014 were provided by the National Center for Health Statistics. CRC incidence rates are highest in Alaska Natives and blacks and lowest in Asian/Pacific Islanders, and they are 30% to 40% higher in men than in women. Recent temporal patterns are generally similar by race and sex, but differ by age. Between 2000 and 2013, incidence rates in adults aged ≥50 years declined by 32%, with the drop largest for distal tumors in people aged ≥65 years (incidence rate ratio [IRR], 0.50; 95% confidence interval [95% CI], 0.48-0.52) and smallest for rectal tumors in ages 50 to 64 years (male IRR, 0.91; 95% CI, 0.85-0.96; female IRR, 1.00; 95% CI, 0.93-1.08). Overall CRC incidence in individuals ages ≥50 years declined from 2009 to 2013 in every state except Arkansas, with the decrease exceeding 5% annually in 7 states; however, rectal tumor incidence in those ages 50 to 64 years was stable in most states. Among adults aged <50 years, CRC incidence rates increased by 22% from 2000 to 2013, driven solely by tumors in the distal colon (IRR, 1.24; 95% CI, 1.13-1.35) and rectum (IRR, 1.22; 95% CI, 1.13-1.31). Similar to incidence patterns, CRC death rates decreased by 34% among individuals aged ≥50 years during 2000 through 2014, but increased by 13% in those aged <50 years. Progress against CRC can be accelerated by increasing initiation of screening at age 50 years (average risk) or earlier (eg, family history of CRC/advanced adenomas) and eliminating disparities in high-quality treatment. In addition, research is needed to elucidate causes for increasing CRC in young adults. CA Cancer J Clin 2017. © 2017 American Cancer Society. CA Cancer J Clin 2017;67:177-193. © 2017 American Cancer Society.
Keywords: colon and rectum neoplasms; epidemiology; health disparities; screening and early detection.
© 2017 American Cancer Society.
Comment in
-
Colorectal cancer rates are rising in younger adults.JAAPA. 2018 Dec;31(12):10-11. doi: 10.1097/01.JAA.0000547755.61546.6c. JAAPA. 2018. PMID: 30418294 No abstract available.
Similar articles
-
Colorectal cancer statistics, 2020.CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5. CA Cancer J Clin. 2020. PMID: 32133645
-
Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.Cancer. 2009 May 1;115(9):1967-76. doi: 10.1002/cncr.24216. Cancer. 2009. PMID: 19235249
-
Colorectal cancer statistics, 2014.CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17. doi: 10.3322/caac.21220. Epub 2014 Mar 17. CA Cancer J Clin. 2014. PMID: 24639052
-
Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer.Gastroenterology. 2022 Jan;162(1):285-299. doi: 10.1053/j.gastro.2021.10.007. Epub 2021 Nov 15. Gastroenterology. 2022. PMID: 34794816 Review.
-
Colorectal cancer disparities: issues, controversies and solutions.World J Gastroenterol. 2014 Jan 28;20(4):869-76. doi: 10.3748/wjg.v20.i4.869. World J Gastroenterol. 2014. PMID: 24574761 Free PMC article. Review.
Cited by
-
Hypermethylation of the sodium channel beta subunit gene promoter is associated with colorectal cancer.Hereditas. 2024 Oct 17;161(1):39. doi: 10.1186/s41065-024-00340-0. Hereditas. 2024. PMID: 39415304 Free PMC article.
-
Reduced Proline-Rich Tyrosine Kinase 2 Promotes Tumor Metastasis by Activating Epithelial-Mesenchymal Transition in Colorectal Cancer.Dig Dis Sci. 2024 Nov;69(11):4098-4107. doi: 10.1007/s10620-024-08643-y. Epub 2024 Oct 16. Dig Dis Sci. 2024. PMID: 39414740
-
Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways.BJS Open. 2024 Sep 3;8(5):zrae119. doi: 10.1093/bjsopen/zrae119. BJS Open. 2024. PMID: 39404039 Free PMC article.
-
AMIGO2 enhances the invasive potential of colorectal cancer by inducing EMT.Cancer Gene Ther. 2024 Oct 8. doi: 10.1038/s41417-024-00842-z. Online ahead of print. Cancer Gene Ther. 2024. PMID: 39379686
-
Impact of Dose-Escalated Chemoradiation on Pathological Complete Response in Patients with Locally Advanced Rectal Cancer.Cancers (Basel). 2024 Sep 16;16(18):3170. doi: 10.3390/cancers16183170. Cancers (Basel). 2024. PMID: 39335142 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
